Flurbiprofen: Clinical Trials

55 trials of Flurbiprofen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

43 completed, 7 unknown, 2 not yet recruiting, 2 recruiting. 25 Phase 1, 9 Phase 4, 8 Not applicable, 6 Phase 2, 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 125Completed 24, Recruiting 1
Phase 49Completed 6, Unknown 2, Not yet recruiting 1
Not applicable8Completed 3, Unknown 3, Active not recruiting 1, Recruiting 1
Phase 26Completed 4, Not yet recruiting 1, Unknown 1
Early Phase 13Completed 2, Unknown 1
Phase 33Completed 3

Follow Flurbiprofen: new trials by email Literature Review of Flurbiprofen trials Research Report on Flurbiprofen

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multiple-dose Study Investigating the Drug-drug Interaction Potential and QTc Effects of Fosmanogepix in Healthy Adult Subjects
Fosmanogepix, Placebo, The medicine cocktail (caffeine, bupropion, flurbiprofen, omeprazole, dextromethorphan and midazolam) - Healthy Adult Participants
Phase 1RecruitingBasilea Pharmaceutica422026-10-012026-10-19
Efficacy and Safety of Anrikefon Injection for the Treatment of Postoperative Pain in Patients Undergoing Laparoscopic Hepatectomy
Anrikefon Injection, Flurbiprofen - Pain Management
Phase 2Not yet recruitingTianjin Medical University Cancer Institute and Hospital1082026-09-012026-09-17
Effects of Flurbiprofen Spray and Ice Cream for Pain and Voice Outcomes After Thyroidectomy
Flurbiprofen, Food Effect cohort, Placebo Control - Thyroidectomy, Sore Throat
Phase 4Not yet recruitingIzmir Katip Celebi University1002026-04-012026-04-15
Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants
Repotrectinib, Metformin, Digoxin - Healthy Volunteers
Phase 1CompletedBristol-Myers Squibb302025-12-312026-03-27
Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants
Vorasidenib, Bupropion, Flurbiprofen - Healthy Adult Participants
Phase 1CompletedInstitut de Recherches Internationales Servier (I.R.I.S.)282025-10-072026-02-17
Efficacy of Flurbiprofen Spray for Postoperative Sore Throat Following Double-Lumen Endobronchial Intubation
Flurbiprofen 8.75 MG, Saline spray - Post Operative Sore Throat, Hoarseness
Not applicableActive not recruitingKittitorn Supphapipat, MD582025-09-102026-03-24
To Assess the Bioavailability of TK-254RX in Comparison with Oral Flurbiprofen Tablets and the Adhesion of TK-254RX in Healthy Subjects
Esflurbiprofen Topical System, Flurbiprofen tablet - Healthy
Phase 1CompletedTeikoku Seiyaku Co., Ltd.262025-01-212025-03-11
Electroencephalographic Characteristics of Chronic Pain in Patients With Spinal Cord Injury
Esketamine(Continuous infusion), Remifentanil (Target-Controlled Infusion), Flurbiprofen (Single intravenous injection) - Chronic Pain
Not applicableUnknownBeijing Tiantan Hospital602024-08-252024-08-13
KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism
Caffeine Tablet, Bupropion Hydrochloride Capsels, Repaglinide Capsels - Drug Interaction
Not applicableCompletedHelsinki University Central Hospital122024-08-222026-03-06
Flurbiprofen Tablet vs Spray In Oral Soft Tissue Wounds
Flurbiprofen - Oral Soft Tissue Conditions, Drug Effect
Phase 4CompletedYuzuncu Yil University402023-10-262024-07-26
Effect of Over-the-counter NSAIDS on Cough Reflex Sensitivity in Patients with Upper Respiratory Tract Infections
Flurbiprofen Oral Lozenge, Difflam, Flurbiprofen 8.75 MG - Cough, Upper Respiratory Tract Infections
Early Phase 1CompletedUniversity of Melbourne1012023-07-012024-12-06
A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants
BMS-986419, Caffeine, Bupropion - Healthy Volunteers
Phase 1CompletedBristol-Myers Squibb222023-06-292023-10-30
A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy Participants
BMS-986196, Caffeine, Montelukast - Healthy Volunteers
Phase 1CompletedBristol-Myers Squibb182023-05-312023-09-26
Voxelotor CYP and Transporter Cocktail Interaction Study
Voxelotor, Bupropion, Repaglinide - Sickle Cell Disease
Phase 1CompletedPfizer442023-04-172024-11-22
Flurbiprofen Versus Aloe Vera Gel in the Treatment of Chronic Periodontitis in Smoking Patients.
2.5% flurbiprofen, 98% aloe vera, Placebo - Periodontitis Chronic Generalized Severe
Phase 4CompletedBeirut Arab University602022-09-302023-09-18
A Study to Investigate the Effect of Single and Repeated Oral Doses of ACT-539313 on What the Body Does to Flurbiprofen, Omeprazole, Midazolam in Healthy Subjects
ACT-539313, Flurbiprofen, Omeprazole - Healthy
Phase 1CompletedIdorsia Pharmaceuticals Ltd.222022-02-182022-05-04
The Effects of NSAIDs on Bone Metabolism Following Exercise
Ibuprofen 800 mg, Celecoxib 200mg, Flurbiprofen 100 mg - Bone Resorption, Stress Fracture
Phase 1CompletedUnited States Army Research Institute of Environmental Medicine122022-02-152023-11-29
The Comparison of the Analgesic Effects of Dezocine and Sufentanil in Patient-controlled Analgesia After Laryngectomy
Dezocine, Sufentanil injection, Flurbiprofen - Patient-controlled Analgesia
Not applicableCompletedEye & ENT Hospital of Fudan University1292022-02-102023-08-21
Remimazolam Tosilate Sedation and Midazolam Sedation in Dental Patients
Fentanyl, Flurbiprofen, Midazolam - Sedation Complication, Midazolam
Phase 4CompletedPeking University812021-04-012022-03-15
Oro-tracheal Intubation: Flurbiprofen Subglottic Instillation to Prevent Laryngeal Inflammation
Flurbiprofen, saline solution - D010612
Phase 2UnknownFondazione Policlinico Universitario Agostino Gemelli IRCCS702021-01-012021-01-14

Showing 20 of 55. Sign in to see all of them.

Conditions studied

Pharyngitis (5)  ·  Arthritis, Rheumatoid (3)  ·  Pain (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Agnosia (2)  ·  Infections (2)  ·  Respiratory Tract Infections (2)  ·  Anemia (1)  ·  Anemia, Sickle Cell (1)  ·  Arthritis (1)  ·  Bone Resorption (1)  ·  Chronic Pain (1)  ·  Cough (1)  ·  Deglutition Disorders (1)  ·  Depression (1)

Sponsors

Bristol-Myers Squibb (7)  ·  GlaxoSmithKline (4)  ·  Reckitt Benckiser LLC (3)  ·  Chinese Medical Association (2)  ·  Jules Desmeules (2)  ·  University Hospital, Geneva (2)  ·  Abliva AB (1)  ·  Basilea Pharmaceutica (1)  ·  Beijing Tiantan Hospital (1)  ·  Beirut Arab University (1)  ·  Changhai Hospital (1)  ·  Dexcel Pharma Technologies Ltd. (1)  ·  Express Specialty Pharmacy (1)  ·  Eye & ENT Hospital of Fudan University (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)

Countries

United States (16)  ·  China (9)  ·  Germany (4)  ·  Switzerland (4)  ·  United Kingdom (4)  ·  Israel (3)  ·  Turkey (Türkiye) (3)  ·  Australia (2)  ·  Finland (1)  ·  France (1)  ·  Jordan (1)  ·  Lebanon (1)  ·  Netherlands (1)  ·  South Korea (1)  ·  Thailand (1)

Top investigators

Timothy J Shea, BS (2)  ·  Abdullah AlAlwani, DDS (1)  ·  Celia Lloret-Linares, MD, PhD (1)  ·  Cennet N Eroglu, DDS,PhD (1)  ·  David Polak, DMD PhD (1)  ·  Dr. Rana T. Bustami, Ph.D. of Pharmacy (1)  ·  Emanuel DeNoia, MD (1)  ·  Frank Donath, MD (1)  ·  Jie Li (1)  ·  Joseph Chiesa, MD (1)  ·  Jules A Desmeules, Pr (1)  ·  Kate McLellan, PhD (1)

Results publications

PMID 25296661, PMID 22288567, PMID 24018772, PMID 24722393, PMID 24988909, PMID 26547293, PMID 27146963, PMID 27878474, PMID 29381110, PMID 29570971, PMID 30007054, PMID 37800597

NIH funding

2019 (1), 2023 (1), R01GM069753 (1)